Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adefovir after surgery for hepatitis B-related primary liver cancer
ChiCTR-TRC-08000090Phase 4Completed
- Sponsor
- Eastern Hepatobiliary Surgery Hospital
- Start
- Jun 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of adefovir dipivoxil in hepatocellular carcinoma (HCC) and Chronic Hepatitis B (CHB) (2 arms), sponsored by Eastern Hepatobiliary Surgery Hospital. Primary endpoints: Relapse of cancer, Quality of life and 1 more. Started Jun 2007; status: completed.
02
Drugs
adefovir dipivoxil
03
Conditions
hepatocellular carcinoma (HCC)Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on ChiCTR-TRC-08000090.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-08000090.